[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338168-105":59,"doc-detail-338168-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-exploration-of-pno1-a-prospective-prognostic-biomarker-with-ties-to-immune-infiltration","Pan-cancer exploration of PNO1 - A prospective prognostic biomarker with ties to immune infiltration","","Partner of NOB1 homolog (PNO1) is an RNA-binding protein involved in ribosome biogenesis and protein modification, with largely unclear cancer functions, especially in breast cancer. Using bioinformatics analyses integrating TCGA, GTEx, HPA, CCLE, UALCAN, GDSC, and UCSC XENA, researchers assessed expression, methylation, survival, gene copy number, and immune relationships across 33 tumor types. Results show PNO1 overexpression in 31 malignancies, prognostic relevance, reduced promoter methylation in multiple cancers, and that PNO1 inhibition reduces breast cancer cell viability, migration, invasion, and alters tumor microenvironment, immune infiltration, chemotherapy sensitivity, and PD-L1 expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-exploration-of-pno1-a-prospective-prognostic-biomarker-with-ties-to-immune-infiltration/338168/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-exploration-of-pno1-a-prospective-prognostic-biomarker-with-ties-to-immune-infiltration/338168.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PNO1 and why is it important for cancer research?","Question",{"text":112,"@type":113},"PNO1 is an RNA-binding protein related to ribosome biogenesis and protein modification. Its cancer roles are largely unknown, motivating pan-cancer and breast-cancer-focused investigation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was PNO1 analyzed across cancers in this study?",{"text":117,"@type":113},"The study used bioinformatics and multiple public databases (TCGA, GTEx, HPA, CCLE, UALCAN, GDSC, and UCSC XENA) to evaluate PNO1 expression, survival prognosis, promoter methylation, and gene copy number alterations across 33 cancer types.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects does PNO1 inhibition have on breast cancer?",{"text":121,"@type":113},"Inhibition of PNO1 decreased breast cancer cell viability, migration, and invasion, supported by mouse xenograft models. It also influenced tumor microenvironment features, immune infiltration, chemotherapy sensitivity, and correlated positively with PD-L1 expression across breast carcinoma samples.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338168,1790663127,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Heliyon 10 (2024) e36819  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration\u003Cbr>Yinhui Qin a , Zhen Lib, Xianwei Zhang b, Junjun Li c , Yuetai Teng d , Na Zhang e , Shengyu Zhao f, Lingfei Kong b, * , Weihong Niu b, **\u003Cbr>a Department of Pharmacy, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Zhengzhou, 450003, Henan, China\u003Cbr>b Department of Pathology, Henan Key Laboratory for Digital Pathology Medicine, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Zhengzhou, 450003, Henan, China\u003Cbr>c The Fourth Affiliated Hospital, Zhejiang University School of Medicine, No. N1 Shangcheng Avenue, Hangzhou, 310058, Zhejiang, China d Department of Pharmacy, Jinan Vocational College of Nursing, Jinan, 250102, China\u003Cbr>e Shandong Academy of Chinese Medicine, Jinan, 250014, China f Shenyang Pharmaceutical University, Shenyang, 110016, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: PNO1\u003Cbr>Breast cancer Prognosis Immune infiltration Biomarker |  | The partner of NOB1 homolog (PNO1) is an RNA-binding protein that participates in ribosome biogenesis and protein modification. The functions of this molecule are largely unknown in cancers, particularly breast cancer. We employed bioinformatics methods to probe the putative oncogenic functions of PNO1 based on expression profiles and clinical data from the cancer genome atlas (TCGA), genotype-tissue expression project (GTEx), human protein atlas (HPA), cancer cell line encyclopedia (CCLE), UALCAN, drug sensitivity in cancer (GDSC) and UCSC XENA databases. Our analyses revealed that PNO1 was overexpressed in 31 malignancies, which excluded kidney chromophobe (KICH) and acute myeloid leukemia (LAML). Prognostic assessments have demonstrated that high PNO1 expression was significantly correlated with poor overall and disease-specific survival in various cancers. The promoter methylation level of PNO1 is significantly decreased in breast invasive carcinoma (BRCA), head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma (KIRP), prostate adenocarcinoma (PRAD), thyroid carcinoma (THCA) and uterine corpus endometrial carcinoma (UCEC). Furthermore, inhibition of PNO1 decreased the viability, migration and invasion of breast cancer cells, and these results were confirmed by mouse xenograft models of breast cancer. In addition, we discovered that tumor microenvironment (TME), immune infiltration, and chemotherapy sensitivity were influenced by PNO1 expression. Concordantly, our analyses revealed a significant positive correlation between PNO1 and programmed cell death ligand 1 (PD-L1) expression across breast carcinoma samples. In conclusion, these findings indicate that PNO1 could act as a promising prognostic biomarker and adjunct diagnostic indicator, because it affects tumor growth and invasion. Our study offers valuable new perspectives on the oncogenic role of PNO1 in various types of cancers. |\n\n* Corresponding author.  \n** Corresponding author.  \nE-mail addresses: [klfhnrnyy@163.com](klfhnrnyy@163.com) (L. Kong), [nwh1006@zzu.edu.cn](nwh1006@zzu.edu.cn) (W. Niu).  \n[https://doi.org/10.1016/j.heliyon.2024.e36819](https://doi.org/10.1016/j.heliyon.2024.e36819)  \nReceived 4 September 2023; Received in revised form 21 August 2024; Accepted 22 August 2024 Available online 23 August 2024  \n2405-8440/© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n1. Introduction  \nBurgeoning global population growth and aging have","cbCaieaWvgin6w6V","https://ap.wps.com/l/cbCaieaWvgin6w6V","pdf",24769251,21,"English","# Introduction\n## Pan-cancer analysis approach\n## Evaluation of expression, prognosis, and molecular alterations\n## Association with tumor microenvironment and immune biomarkers\n## Breast cancer functional validation","[{\"question\":\"What is PNO1 and why is it important for cancer research?\",\"answer\":\"PNO1 is an RNA-binding protein related to ribosome biogenesis and protein modification. Its cancer roles are largely unknown, motivating pan-cancer and breast-cancer-focused investigation.\"},{\"question\":\"How was PNO1 analyzed across cancers in this study?\",\"answer\":\"The study used bioinformatics and multiple public databases (TCGA, GTEx, HPA, CCLE, UALCAN, GDSC, and UCSC XENA) to evaluate PNO1 expression, survival prognosis, promoter methylation, and gene copy number alterations across 33 cancer types.\"},{\"question\":\"What functional effects does PNO1 inhibition have on breast cancer?\",\"answer\":\"Inhibition of PNO1 decreased breast cancer cell viability, migration, and invasion, supported by mouse xenograft models. It also influenced tumor microenvironment features, immune infiltration, chemotherapy sensitivity, and correlated positively with PD-L1 expression across breast carcinoma samples.\"}]","Pan-cancer exploration of PNO1 - A prospective prognostic biomarker with ties to immune infiltration | PDF",1790022322,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f65fdb6e9c978cc12db08b7f57ce70f5.webp",983,1341,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb6842850933c84b56c2013ef063e382.webp",982,1340,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3150477391729e46ff286e4e2721bf10.webp",981,1338,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60dbca7eb8c56e5f5d81c19d183dbfd6.webp",980,1337]